Skip to main content

UBS Group AG

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1610520 ZURICH, V8

Position in FENC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$50,621
+$10,820 QoQ
Shares Held
4,709
-27.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 104 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 63% Shared 0% None 37%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. FENC ranks #393 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FENC

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,621 4,709
2026-03-31 $39,801 6,472
2025-12-31 $38,459 4,995
2025-09-30 $128,323 13,710
2025-06-30 $108,098 13,024
2025-03-31 $159,885 26,254
2024-12-31 $98,098 15,522
2024-09-30 $56,115 11,223
2024-06-30 $44,407 7,268
2024-03-31 $329,351 29,618
2023-12-31 $224,052 19,969
2023-09-30 $75,024 9,990
2023-06-30 $92,997 10,532
2023-03-31 $5,865 705
2022-12-31 $614 64
2022-09-30 $25,101 3,099
2022-06-30 $357 64
2022-03-31 $6,137 1,096
2021-12-31 $34,218 7,777
2021-09-30 $602 64
2021-06-30 $430,007 58,986
2021-03-31 $251,933 40,569
2020-12-31 $26,447 3,550
2020-06-30 $57,506 6,887